11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Exposure to potent synthetic opioids such as illicitly manufactured fentanyl (IMF) has fueled the escalating overdose crisis in the USA, particularly in the east coast. Drug checking services, which allow people who use drugs (PWUD) to learn about the contents of their drugs, remain limited and even criminalized in many states. Further, there is a persistent belief that PWUD are not willing or able to change their behaviors despite being aware of their potential exposure to fentanyl through drug use.

          Methods

          We conducted a multi-site cross-sectional study among PWUD to assess what behaviors, if any, were employed in the case of suspected fentanyl exposure, and the correlates of engaging in harm reduction behaviors (HRB). PWUD ( N = 334) were recruited in Boston ( n = 80), Providence ( n = 79), and in Baltimore ( n = 175). At the time of the survey, no legal drug checking services were available in these cities.

          Results

          The majority of PWUD (84%) expressed concern about fentanyl. Among those who suspected fentanyl exposure prior to using their drugs ( n = 196), 39% reported employing HRB including using less of the drug (12%) or abstaining altogether (10%), using more slowly (5%), and doing a tester shot (5%). In adjusted logistic regression models, the odds (aOR) of practicing HRB after suspecting fentanyl exposure were increased among PWUD who were non-White (aOR 2.1; p = 0.004) and older (aOR 1.52 per decade of age; p < 0.001). Daily injection (aOR 0.50; p < 0.001), using drugs in public (aOR 0.58; p = 0.001), using drugs alone (aOR 0.68; p < 0.001), and experiencing multiple recent overdoses (aOR 0.55; p < 0.001) were associated with decreased odds of practicing HRB.

          Conclusions

          These data illustrate that PWUD employ a number of practices to reduce overdose risk in a context of unknown drug purity and content. Results may also guide efforts to identify early adopters of drug checking services and engage them in peer-outreach to target the most socially and structurally vulnerable PWUD, who are not reporting behavior change, with harm reduction messaging.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          The social structural production of HIV risk among injecting drug users.

          There is increasing appreciation of the need to understand how social and structural factors shape HIV risk. Drawing on a review of recently published literature, we seek to describe the social structural production of HIV risk associated with injecting drug use. We adopt an inclusive definition of the HIV 'risk environment' as the space, whether social or physical, in which a variety of factors exogenous to the individual interact to increase vulnerability to HIV. We identify the following factors as critical in the social structural production of HIV risk associated with drug injecting: cross-border trade and transport links; population movement and mixing; urban or neighbourhood deprivation and disadvantage; specific injecting environments (including shooting galleries and prisons); the role of peer groups and social networks; the relevance of 'social capital' at the level of networks, communities and neighbourhoods; the role of macro-social change and political or economic transition; political, social and economic inequities in relation to ethnicity, gender and sexuality; the role of social stigma and discrimination in reproducing inequity and vulnerability; the role of policies, laws and policing; and the role of complex emergencies such as armed conflict and natural disasters. We argue that the HIV risk environment is a product of interplay in which social and structural factors intermingle but where political-economic factors may play a predominant role. We therefore emphasise that much of the most needed 'structural HIV prevention' is unavoidably political in that it calls for community actions and structural changes within a broad framework concerned to alleviate inequity in health, welfare and human rights.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Changes in Synthetic Opioid Involvement in Drug Overdose Deaths in the United States, 2010-2016

            This study uses National Vital Statistics System data to describe trends in synthetic opioid involvement in drug overdose deaths in the United States from 2010 to 2016.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States

              In 2016, the number of overdose deaths involving illicitly-manufactured fentanyl (IMF) surpassed heroin and prescription opioid deaths in the United States for the first time, with IMF-involved overdose deaths increasing more than 500% across 10 states from 2013 to 2016. IMF is an extremely potent synthetic opioid that is regularly mixed with heroin and often sold to unwitting consumers. Community-based organizations have started to distribute fentanyl test strips (FTS) as a strategy to identify IMF in street purchased products. We investigated the association between FTS use and changes in drug use behavior and perceived overdose safety among a community-based sample of people who inject drugs (PWID) in the United States.
                Bookmark

                Author and article information

                Contributors
                9176362921 , srouhan1@jhu.edu
                Journal
                Harm Reduct J
                Harm Reduct J
                Harm Reduction Journal
                BioMed Central (London )
                1477-7517
                24 June 2019
                24 June 2019
                2019
                : 16
                : 39
                Affiliations
                [1 ]ISNI 0000 0001 2171 9311, GRID grid.21107.35, Department of Health, Behavior, and Society, , Johns Hopkins Bloomberg School of Public Health, ; 624 N Broadway, Baltimore, MD 21205 USA
                [2 ]ISNI 0000 0004 1936 9094, GRID grid.40263.33, Miriam Hospital and Alpert Medical School of Brown University, ; Providence, RI USA
                Author information
                http://orcid.org/0000-0003-3801-1082
                Article
                311
                10.1186/s12954-019-0311-9
                6591810
                31234942
                77ac8851-c461-4ed2-bebb-fa85d1e8f058
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 28 March 2019
                : 30 May 2019
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100011780, Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health;
                Award ID: 1P30AI094189
                Award Recipient :
                Funded by: Johns Hopkins Bloomberg School of Public Health (US)
                Award ID: NA
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000026, National Institute on Drug Abuse;
                Award ID: NA
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2019

                Health & Social care
                fentanyl,overdose,harm reduction,drug checking
                Health & Social care
                fentanyl, overdose, harm reduction, drug checking

                Comments

                Comment on this article